JYP0322

· Guangzhou JOYO Pharma Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JYP0322, covering 2025-07-14 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs. [Phase 3]

See pricing